The BOOG 2013-08 trial evaluates whether SLNB can be safely omitted for patients with clinically T1-2N0 treated with breast-conserving surgery and whole-breast irradiation.
Omitting sentinel lymph node biopsy (SLNB) in patients with early-stage breast cancer undergoing breast-conserving surgery may not increase the risk for recurrence over 5 years, according to findings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results